BioCentury
ARTICLE | Company News

TSI Corp. sales and marketing update

November 8, 1993 8:00 AM UTC

A restructured TSIN reported profits of $117,000 (1 cent per share) on revenues of $13.8 million in its first quarter ended Sept. 26. The company lost $474,000 (2 cents) on revenues of $14.7 million in the quarter last year, and suffered a $32 million loss for all of the 1993 fiscal period. Preclinical and clinical testing services revenues were $11.1 million vs. $11.4 million in the quarter last year. ...